Responsibilities and Requirements of Prescribing Schedule II Opioid Drugs Works Cited 1. Federation of State Medical Boards. Guidelines for the Chronic Use of Opioid Analgesics . Washington, DC: The Federation of State Medical Boards; 2017. 2. Institute of Medicine, Committee on Advancing Pain Research, Care, and Education. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research . Washington, DC: The National Academies Press; 2011. 3. Kenen K, Mack K, Paulozzi L. Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000–2010. Open Medicine . 2012;6(2)e41. 4. Owen GT, Burton AW, Schade CM, Passik S. Urine drug testing: current recommendations and best practices. Pain Physician . 2012;15:ES119- ES133. 5. Centers for Disease Control and Prevention. Dental Pain Care. Available at https://www.cdc.gov/opioids/healthcare-professionals/ prescribing/dental-pain.html. Last accessed January 12, 2024. 6. Miller NS, Greenfeld A. Patient characteristics and risks factors for development of dependence on hydrocodone and oxycodone. Am J Ther . 2004;11:26-32. 7. Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 2006: National Estimates of Drug-Related Emergency Department Visits . Rockville, MD: U.S. Department of Health and Human Services; 2007. 8. Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits . Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014. 9. Management of Opioid Therapy for Chronic Pain Working Group. VA/DoD Clinical Practice Guideline for Opioid Therapy for Chronic Pain . Washington, DC: Department of Veterans Affairs, Department of Defense; 2017. 10. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR . 2016;65(1):1-49. 11. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain . 2009;10(2):113-130. 12. Centers for Disease Control and Prevention. About CDC’s Opioid Prescribing Guideline. Available at https://www.cdc.gov/drugoverdose/ prescribing/guideline.html. Last accessed January 12, 2024. 13. Argoff CE, Silvershein DI. A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs. Mayo Clin Proc . 2009;84(7):602-612. 14. McCarberg BH, Barkin RL. Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia. Am J Ther . 2001;8(3):181-186. 15. National Comprehensive Cancer Network. Adult Cancer Pain, 2021. Available at https://www.nccn.org/professionals/physician_gls/pdf/pain. pdf. Last accessed January 12, 2024. 16. U.S. Food and Drug Administration. Medication Guides: Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS). Available at https://www.fda.gov/media/79776/download. Last accessed January 12, 2024. 17. Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2—guidance. Pain Physician . 2012;15(3 Suppl):S67-S116. 18. Cheattle MD. Risk Assessment: Safe Opioid Prescribing Tools. Available at https://www.practicalpainmanagement.com/resource-centers/ opioid-prescribing-monitoring/risk-assessment-safe-opioid-prescribing-tools. Last accessed January 12, 2024. 19. Butler SF, Budman SH, Fernandez KC, Fanciullo GJ, Jamison RN. Cross-validation of a Screener to Predict Opioid Misuse in Chronic Pain Patients (SOAPP-R). J Addict Med . 2009;3(2):66-73. 20. Singer JA. Harm Reduction: Shifting from a War on Drugs to a War on Drug-Related Deaths. Available at https://www.cato.org/policy- analysis/harm-reduction-shifting-war-drugs-war-drug-related-deaths. Last accessed January 12, 2024. 21. Fine PG, Finnegan T, Portenoy RK. Protect your patients, protect your practice: practical risk assessment in the structuring of opioid therapy in chronic pain. J Fam Pract . 2010;59(9 Suppl 2):S1-S16. 22. Katz NP. Opioid Prescribing Toolkit: A Workbook for Clinicians . New York, NY: Oxford University Press; 2010. 23. American Chronic Pain Association. ACPA– Stanford Resource Guide to Pain Management: 2020 Edition. Available at https://www.theacpa. org/wp-content/uploads/2020/03/ACPA-Resource-Guide-2020-2-26-2020.pdf. Last accessed April 22, 2021. 24. Strickland JM, Huskey A, Brushwood DB. Pharmacist-physician collaboration in pain management practice. J Opioid Manag . 2007;3:295-301. 25. Brushwood DB. Screening Controlled Substance Prescriptions for Legitimacy: The VIGIL System. Available at http://www.empaa.org/ downloads/EMPAA2010/presentation/BrushwoodDavid_VIGIL_EMPAA2010.pdf. Last accessed April 22, 2021. 26. Miner J, Babitz M, Dunn A, Fondario A, Smith M. Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain . Salt Lake City, UT: Utah Department of Health; 2018. 27. U.S. Food and Drug Administration. FDA Warns About Dental Problems with Buprenorphine Medicines Dissolved in the Mouth to Treat Opioid Use Disorder and Pain. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-dental-problems- buprenorphine-medicines-dissolved-mouth-treat-opioid-use-disorder. Last accessed January 12, 2024. 28. Kaye AD, Jones MR, Kaye AM, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse (part 2). Pain Physician . 2017;20(Supp 2):S111-S133. 29. American Society of Anesthesiologists. Opioid Abuse. Available at https://www.asahq.org/madeforthismoment/pain-management/opioid- treatment/opioid-abuse. Last accessed April 22, 2021.
Powered by FlippingBook